Nova Life Medical ABActive
Key figures
Key figures
2025Balance structure
Summary of annual reports2020–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 1 333 000 | 1 420 000 | 1 009 000 | 853 000 | 485 000 |
| Profit for the reporting year | 217 308 | 147 673 | 46 037 | 104 703 | 3 698 |
| Retained earnings of previous periods | — | — | — | — | — |
| Total assets | 801 280 | 719 921 | 667 745 | 501 600 | 252 693 |
| Total liabilities | 153 207 | 174 175 | 325 962 | 205 114 | 202 509 |
| Total equity | 648 073 | 545 746 | 341 783 | 296 486 | 50 184 |
| Employees | 2 | 2 | 2 | 1 | 1 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: Nova Life Medical AB
Overview
Nova Life Medical AB (org. no. 556557-6088) is a limited company (AB). The company was registered in 1998 and has existed for 28 years. Registered seat: Malmö. Industry according to Statistics Sweden: wholesale of pharmaceutical and medical goods (SNI 46460).
Economy
Net sales in financial year 2025 were 485 000 kr, down 43,1 % on the previous year (853 000 kr). From 2020 to 2025, net sales declined by an average of 18,9 % per year. This is the lowest net sales among the reported years (2020–2025). Net profit for 2025 was 3 698 kr (0,8 % of net sales). The company was profitable in all 6 reported financial years. Employees in financial year 2025: 1. Net sales per employee were 485 000 kr. At the end of financial year 2025, total assets were 252 693 kr and equity 50 184 kr (equity ratio 19,9 %).
Sources and freshness
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-02. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.